Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 7.89265903 |
2 | epoxygenase P450 pathway (GO:0019373) | 7.72829493 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58897369 |
4 | L-phenylalanine catabolic process (GO:0006559) | 7.58897369 |
5 | omega-hydroxylase P450 pathway (GO:0097267) | 7.46854231 |
6 | L-phenylalanine metabolic process (GO:0006558) | 7.24506413 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24506413 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.84195886 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.33330656 |
10 | tryptophan catabolic process (GO:0006569) | 6.24484390 |
11 | indole-containing compound catabolic process (GO:0042436) | 6.24484390 |
12 | indolalkylamine catabolic process (GO:0046218) | 6.24484390 |
13 | kynurenine metabolic process (GO:0070189) | 6.13755375 |
14 | bile acid biosynthetic process (GO:0006699) | 6.02886235 |
15 | glyoxylate metabolic process (GO:0046487) | 5.91451957 |
16 | tryptophan metabolic process (GO:0006568) | 5.86739809 |
17 | negative regulation of fibrinolysis (GO:0051918) | 5.83152503 |
18 | urea metabolic process (GO:0019627) | 5.65641646 |
19 | urea cycle (GO:0000050) | 5.65641646 |
20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.65087750 |
21 | regulation of plasminogen activation (GO:0010755) | 5.63685718 |
22 | regulation of protein activation cascade (GO:2000257) | 5.61716100 |
23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56506218 |
24 | complement activation, alternative pathway (GO:0006957) | 5.55888979 |
25 | protein carboxylation (GO:0018214) | 5.51573740 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.51573740 |
27 | cysteine metabolic process (GO:0006534) | 5.30809304 |
28 | * regulation of fibrinolysis (GO:0051917) | 5.29070332 |
29 | sulfur amino acid catabolic process (GO:0000098) | 5.26738157 |
30 | regulation of complement activation (GO:0030449) | 5.24213434 |
31 | nitrogen cycle metabolic process (GO:0071941) | 5.19481689 |
32 | drug metabolic process (GO:0017144) | 5.19008737 |
33 | bile acid metabolic process (GO:0008206) | 5.12005733 |
34 | intestinal cholesterol absorption (GO:0030299) | 5.10409775 |
35 | serine family amino acid catabolic process (GO:0009071) | 5.07743812 |
36 | reverse cholesterol transport (GO:0043691) | 4.97612720 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.96421104 |
38 | ethanol metabolic process (GO:0006067) | 4.95560727 |
39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92222003 |
40 | regulation of cholesterol esterification (GO:0010872) | 4.88799659 |
41 | regulation of humoral immune response (GO:0002920) | 4.88207649 |
42 | protein-lipid complex remodeling (GO:0034368) | 4.84352718 |
43 | macromolecular complex remodeling (GO:0034367) | 4.84352718 |
44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.84352718 |
45 | regulation of triglyceride catabolic process (GO:0010896) | 4.84231439 |
46 | tyrosine metabolic process (GO:0006570) | 4.76854672 |
47 | oxidative demethylation (GO:0070989) | 4.67663249 |
48 | acylglycerol homeostasis (GO:0055090) | 4.67173543 |
49 | triglyceride homeostasis (GO:0070328) | 4.67173543 |
50 | homocysteine metabolic process (GO:0050667) | 4.67005782 |
51 | alpha-amino acid catabolic process (GO:1901606) | 4.62279229 |
52 | phospholipid efflux (GO:0033700) | 4.61699287 |
53 | lysine metabolic process (GO:0006553) | 4.55709249 |
54 | lysine catabolic process (GO:0006554) | 4.55709249 |
55 | negative regulation of cholesterol transport (GO:0032375) | 4.55123545 |
56 | negative regulation of sterol transport (GO:0032372) | 4.55123545 |
57 | amino-acid betaine metabolic process (GO:0006577) | 4.52844078 |
58 | * negative regulation of blood coagulation (GO:0030195) | 4.50983629 |
59 | * negative regulation of hemostasis (GO:1900047) | 4.50983629 |
60 | plasma lipoprotein particle clearance (GO:0034381) | 4.45787180 |
61 | cellular ketone body metabolic process (GO:0046950) | 4.43552993 |
62 | coenzyme catabolic process (GO:0009109) | 4.41862415 |
63 | indolalkylamine metabolic process (GO:0006586) | 4.41692236 |
64 | glycine metabolic process (GO:0006544) | 4.41385022 |
65 | positive regulation of blood coagulation (GO:0030194) | 4.41339129 |
66 | positive regulation of hemostasis (GO:1900048) | 4.41339129 |
67 | imidazole-containing compound metabolic process (GO:0052803) | 4.41050184 |
68 | bile acid and bile salt transport (GO:0015721) | 4.39449532 |
69 | regulation of apoptotic cell clearance (GO:2000425) | 4.37326539 |
70 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.37182198 |
71 | cellular biogenic amine catabolic process (GO:0042402) | 4.32561221 |
72 | amine catabolic process (GO:0009310) | 4.32561221 |
73 | cholesterol efflux (GO:0033344) | 4.32005420 |
74 | negative regulation of complement activation (GO:0045916) | 4.30627015 |
75 | glutamate metabolic process (GO:0006536) | 4.26323431 |
76 | cellular amino acid catabolic process (GO:0009063) | 4.24483028 |
77 | cellular glucuronidation (GO:0052695) | 4.19100103 |
78 | phenylpropanoid metabolic process (GO:0009698) | 4.17741461 |
79 | serine family amino acid metabolic process (GO:0009069) | 4.15851620 |
80 | fibrinolysis (GO:0042730) | 4.13526709 |
81 | benzene-containing compound metabolic process (GO:0042537) | 4.12454075 |
82 | * negative regulation of coagulation (GO:0050819) | 4.11251371 |
83 | plasma lipoprotein particle assembly (GO:0034377) | 4.07957011 |
84 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.07737268 |
85 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.07737268 |
86 | cellular modified amino acid catabolic process (GO:0042219) | 4.06411186 |
87 | ethanol oxidation (GO:0006069) | 4.06320710 |
88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05701458 |
89 | positive regulation of coagulation (GO:0050820) | 4.05622892 |
90 | * negative regulation of wound healing (GO:0061045) | 4.02965774 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 4.02618252 |
92 | aldehyde catabolic process (GO:0046185) | 4.01633247 |
93 | low-density lipoprotein particle remodeling (GO:0034374) | 4.00381859 |
94 | arginine metabolic process (GO:0006525) | 3.99870968 |
95 | protein-lipid complex subunit organization (GO:0071825) | 3.95178687 |
96 | complement activation, classical pathway (GO:0006958) | 3.92388433 |
97 | complement activation (GO:0006956) | 3.86828362 |
98 | drug catabolic process (GO:0042737) | 3.85755242 |
99 | cytolysis (GO:0019835) | 3.84966782 |
100 | ketone body metabolic process (GO:1902224) | 3.83898460 |
101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.83228119 |
102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.83228119 |
103 | phospholipid homeostasis (GO:0055091) | 3.82749158 |
104 | cofactor catabolic process (GO:0051187) | 3.82400614 |
105 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.78124651 |
106 | cholesterol homeostasis (GO:0042632) | 3.77166795 |
107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76772963 |
108 | * protein activation cascade (GO:0072376) | 3.75764970 |
109 | positive regulation of lipid catabolic process (GO:0050996) | 3.74325950 |
110 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73056883 |
111 | negative regulation of lipase activity (GO:0060192) | 3.71475016 |
112 | uronic acid metabolic process (GO:0006063) | 3.71365707 |
113 | glucuronate metabolic process (GO:0019585) | 3.71365707 |
114 | sterol homeostasis (GO:0055092) | 3.70789891 |
115 | organic acid catabolic process (GO:0016054) | 3.69653881 |
116 | carboxylic acid catabolic process (GO:0046395) | 3.69653881 |
117 | plasma lipoprotein particle organization (GO:0071827) | 3.69454442 |
118 | negative regulation of protein activation cascade (GO:2000258) | 3.68606027 |
119 | regulation of cholesterol homeostasis (GO:2000188) | 3.67487677 |
120 | S-adenosylmethionine metabolic process (GO:0046500) | 3.67311241 |
121 | protein-lipid complex assembly (GO:0065005) | 3.65500268 |
122 | acetyl-CoA metabolic process (GO:0006084) | 3.65172249 |
123 | * blood coagulation, intrinsic pathway (GO:0007597) | 3.64150315 |
124 | opsonization (GO:0008228) | 3.62800306 |
125 | acute-phase response (GO:0006953) | 3.59147757 |
126 | acute inflammatory response (GO:0002526) | 3.58206838 |
127 | response to mercury ion (GO:0046689) | 3.51597827 |
128 | flavonoid metabolic process (GO:0009812) | 3.44307244 |
129 | lipoprotein metabolic process (GO:0042157) | 3.43978648 |
130 | regulation of acute inflammatory response (GO:0002673) | 3.43700159 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.36273561 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18423019 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.11276756 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50613256 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29854468 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.12481291 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.75898313 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06583997 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.03428559 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04900551 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0668704 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97969302 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91105775 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62710117 |
15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58371799 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50369675 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45263925 |
18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40213214 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34693707 |
20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25923273 |
21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21280293 |
22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19070422 |
23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16946804 |
24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11663068 |
25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08324733 |
26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07449975 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02754206 |
28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02018562 |
29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94667524 |
30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93953911 |
31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91147885 |
32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88559111 |
33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85494479 |
34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85076595 |
35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83479534 |
36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82373985 |
37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80319751 |
38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78743856 |
39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76815537 |
40 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76339904 |
41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76049640 |
42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75819309 |
43 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75317468 |
44 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75009103 |
45 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74793450 |
46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.74768710 |
47 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74313364 |
48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.72689880 |
49 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.70804911 |
50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70596700 |
51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70534756 |
52 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69605649 |
53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.69052199 |
54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68833232 |
55 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66558952 |
56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65266939 |
57 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64903351 |
58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63983657 |
59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63983657 |
60 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.63328496 |
61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62811654 |
62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60981217 |
63 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.60970175 |
64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.60263885 |
65 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59623834 |
66 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58935787 |
67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.58799456 |
68 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.58037606 |
69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57868723 |
70 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.57279242 |
71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.57066407 |
72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.56960088 |
73 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56372245 |
74 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.56134927 |
75 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.55728224 |
76 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.55688918 |
77 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.55159494 |
78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55045413 |
79 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.54818879 |
80 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.54736153 |
81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54571419 |
82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53058417 |
83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52922829 |
84 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52670963 |
85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52591842 |
86 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.52384348 |
87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.52208426 |
88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51939975 |
89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51195307 |
90 | TP53_16413492_ChIP-PET_HCT116_Human | 0.50986394 |
91 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50859399 |
92 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.50761094 |
93 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.50655264 |
94 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.49682397 |
95 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.49547321 |
96 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.49285683 |
97 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.49218464 |
98 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48854784 |
99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.48441494 |
100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.48126911 |
101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.47949682 |
102 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.47667736 |
103 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47632492 |
104 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.47152026 |
105 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.46673092 |
106 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46507497 |
107 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46221582 |
108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46217154 |
109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45266588 |
110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44332551 |
111 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44265463 |
112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44054034 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43828262 |
114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43767872 |
115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43597829 |
116 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42664257 |
117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42577568 |
118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42125972 |
119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41049346 |
120 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.40335073 |
121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40316539 |
122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40132898 |
123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39867489 |
124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39169406 |
125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38903635 |
126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38902558 |
127 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.38323134 |
128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38275974 |
129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38113236 |
130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37908128 |
131 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35691224 |
132 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35199852 |
133 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34945569 |
134 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34305167 |
135 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33809489 |
136 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33727811 |
137 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.32871918 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.29386215 |
2 | MP0005360_urolithiasis | 7.58999199 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.47987604 |
4 | MP0005365_abnormal_bile_salt | 6.15906045 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.03611786 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.36557274 |
7 | MP0003252_abnormal_bile_duct | 3.92302495 |
8 | MP0010329_abnormal_lipoprotein_level | 3.63812019 |
9 | MP0009840_abnormal_foam_cell | 3.29175735 |
10 | MP0005083_abnormal_biliary_tract | 3.12130362 |
11 | MP0003195_calcinosis | 2.86698820 |
12 | MP0005332_abnormal_amino_acid | 2.72977094 |
13 | MP0001666_abnormal_nutrient_absorption | 2.63031461 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.41839452 |
15 | MP0000609_abnormal_liver_physiology | 2.19114953 |
16 | MP0002118_abnormal_lipid_homeostasis | 2.11063088 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.10249864 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.94968224 |
19 | MP0003868_abnormal_feces_composition | 1.91826086 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84254619 |
21 | MP0003122_maternal_imprinting | 1.77036854 |
22 | MP0001764_abnormal_homeostasis | 1.67825904 |
23 | MP0009697_abnormal_copulation | 1.65698882 |
24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57618868 |
25 | MP0003011_delayed_dark_adaptation | 1.43973161 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 1.32550965 |
27 | MP0005451_abnormal_body_composition | 1.32412702 |
28 | MP0003186_abnormal_redox_activity | 1.23786627 |
29 | MP0009643_abnormal_urine_homeostasis | 1.21953083 |
30 | MP0005647_abnormal_sex_gland | 1.18667913 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.17301124 |
32 | * MP0000598_abnormal_liver_morphology | 1.17025537 |
33 | MP0000604_amyloidosis | 1.11681103 |
34 | MP0002254_reproductive_system_inflammat | 1.10071940 |
35 | MP0009764_decreased_sensitivity_to | 1.07280137 |
36 | MP0009763_increased_sensitivity_to | 1.04484345 |
37 | MP0000566_synostosis | 0.95094955 |
38 | MP0005636_abnormal_mineral_homeostasis | 0.94091469 |
39 | MP0008469_abnormal_protein_level | 0.91683481 |
40 | MP0005058_abnormal_lysosome_morphology | 0.89602290 |
41 | * MP0001915_intracranial_hemorrhage | 0.88406037 |
42 | * MP0009642_abnormal_blood_homeostasis | 0.87447399 |
43 | MP0005408_hypopigmentation | 0.85929039 |
44 | MP0005376_homeostasis/metabolism_phenot | 0.81526577 |
45 | MP0006036_abnormal_mitochondrial_physio | 0.80872418 |
46 | MP0005084_abnormal_gallbladder_morpholo | 0.80354634 |
47 | MP0009765_abnormal_xenobiotic_induced | 0.79102228 |
48 | MP0003172_abnormal_lysosome_physiology | 0.78542998 |
49 | MP0002078_abnormal_glucose_homeostasis | 0.77933895 |
50 | MP0002876_abnormal_thyroid_physiology | 0.77406053 |
51 | MP0005670_abnormal_white_adipose | 0.76279292 |
52 | MP0003879_abnormal_hair_cell | 0.76188771 |
53 | MP0005220_abnormal_exocrine_pancreas | 0.76034774 |
54 | MP0002089_abnormal_postnatal_growth/wei | 0.75707771 |
55 | MP0002971_abnormal_brown_adipose | 0.72011098 |
56 | MP0005334_abnormal_fat_pad | 0.69367194 |
57 | MP0004130_abnormal_muscle_cell | 0.68839132 |
58 | MP0003690_abnormal_glial_cell | 0.68804155 |
59 | MP0005535_abnormal_body_temperature | 0.68219851 |
60 | MP0001661_extended_life_span | 0.67632366 |
61 | MP0009053_abnormal_anal_canal | 0.67230391 |
62 | MP0005266_abnormal_metabolism | 0.65631052 |
63 | MP0000639_abnormal_adrenal_gland | 0.63202694 |
64 | MP0003329_amyloid_beta_deposits | 0.62635539 |
65 | MP0005464_abnormal_platelet_physiology | 0.57774676 |
66 | MP0003123_paternal_imprinting | 0.57719563 |
67 | MP0006035_abnormal_mitochondrial_morpho | 0.56454884 |
68 | MP0001756_abnormal_urination | 0.56294880 |
69 | MP0005448_abnormal_energy_balance | 0.55455518 |
70 | MP0005187_abnormal_penis_morphology | 0.51337853 |
71 | MP0005395_other_phenotype | 0.49966140 |
72 | MP0002822_catalepsy | 0.49399506 |
73 | MP0002909_abnormal_adrenal_gland | 0.48128194 |
74 | MP0003724_increased_susceptibility_to | 0.47414907 |
75 | MP0009780_abnormal_chondrocyte_physiolo | 0.47406110 |
76 | MP0002249_abnormal_larynx_morphology | 0.46863537 |
77 | MP0003718_maternal_effect | 0.46455892 |
78 | MP0003638_abnormal_response/metabolism_ | 0.46440145 |
79 | MP0002928_abnormal_bile_duct | 0.46073623 |
80 | MP0008874_decreased_physiological_sensi | 0.45692501 |
81 | MP0004381_abnormal_hair_follicle | 0.45509015 |
82 | MP0005023_abnormal_wound_healing | 0.45385614 |
83 | MP0003436_decreased_susceptibility_to | 0.44850586 |
84 | MP0004782_abnormal_surfactant_physiolog | 0.44537211 |
85 | MP0002136_abnormal_kidney_physiology | 0.44216167 |
86 | MP0008873_increased_physiological_sensi | 0.44132100 |
87 | MP0004043_abnormal_pH_regulation | 0.42604711 |
88 | MP0002837_dystrophic_cardiac_calcinosis | 0.42107800 |
89 | MP0005409_darkened_coat_color | 0.41729168 |
90 | MP0004272_abnormal_basement_membrane | 0.41571727 |
91 | MP0005167_abnormal_blood-brain_barrier | 0.41035823 |
92 | MP0003953_abnormal_hormone_level | 0.40913756 |
93 | MP0000579_abnormal_nail_morphology | 0.40772174 |
94 | MP0009384_cardiac_valve_regurgitation | 0.38754777 |
95 | MP0005248_abnormal_Harderian_gland | 0.38335423 |
96 | MP0008872_abnormal_physiological_respon | 0.37499308 |
97 | MP0009672_abnormal_birth_weight | 0.37172560 |
98 | MP0001944_abnormal_pancreas_morphology | 0.36237823 |
99 | MP0005666_abnormal_adipose_tissue | 0.35593214 |
100 | MP0002796_impaired_skin_barrier | 0.35394679 |
101 | MP0006082_CNS_inflammation | 0.35320263 |
102 | MP0004883_abnormal_blood_vessel | 0.34810605 |
103 | MP0000249_abnormal_blood_vessel | 0.33482008 |
104 | MP0000920_abnormal_myelination | 0.32688039 |
105 | MP0009115_abnormal_fat_cell | 0.32178782 |
106 | MP0001243_abnormal_dermal_layer | 0.32113390 |
107 | MP0003633_abnormal_nervous_system | 0.31747390 |
108 | MP0002168_other_aberrant_phenotype | 0.30803913 |
109 | MP0003183_abnormal_peptide_metabolism | 0.30766710 |
110 | MP0001881_abnormal_mammary_gland | 0.30402680 |
111 | MP0001853_heart_inflammation | 0.30189480 |
112 | MP0002970_abnormal_white_adipose | 0.30122101 |
113 | MP0003632_abnormal_nervous_system | 0.30057802 |
114 | MP0000230_abnormal_systemic_arterial | 0.29799678 |
115 | MP0001845_abnormal_inflammatory_respons | 0.28990285 |
116 | MP0005379_endocrine/exocrine_gland_phen | 0.28147931 |
117 | MP0003878_abnormal_ear_physiology | 0.27959915 |
118 | MP0005377_hearing/vestibular/ear_phenot | 0.27959915 |
119 | MP0003567_abnormal_fetal_cardiomyocyte | 0.27859893 |
120 | MP0005164_abnormal_response_to | 0.27807488 |
121 | MP0000427_abnormal_hair_cycle | 0.24920509 |
122 | MP0003631_nervous_system_phenotype | 0.24878721 |
123 | MP0009785_altered_susceptibility_to | 0.24820112 |
124 | MP0002060_abnormal_skin_morphology | 0.24803584 |
125 | * MP0005166_decreased_susceptibility_to | 0.24685060 |
126 | MP0005646_abnormal_pituitary_gland | 0.23796497 |
127 | MP0001324_abnormal_eye_pigmentation | 0.23433237 |
128 | MP0002135_abnormal_kidney_morphology | 0.23066518 |
129 | MP0004264_abnormal_extraembryonic_tissu | 0.22937641 |
130 | MP0002090_abnormal_vision | 0.21920647 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.61303462 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.45420591 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.36674413 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.60042925 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.37868028 |
6 | Xanthomatosis (HP:0000991) | 6.28150940 |
7 | * Prolonged partial thromboplastin time (HP:0003645) | 6.27118918 |
8 | Complement deficiency (HP:0004431) | 5.71802416 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.50963933 |
10 | Joint hemorrhage (HP:0005261) | 4.99597389 |
11 | Hypolipoproteinemia (HP:0010981) | 4.84577992 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.69831131 |
13 | Hyperammonemia (HP:0001987) | 4.55558240 |
14 | Epidermoid cyst (HP:0200040) | 4.47812202 |
15 | Hyperglycinemia (HP:0002154) | 4.42539179 |
16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.41891737 |
17 | Hypoalphalipoproteinemia (HP:0003233) | 4.27503734 |
18 | Ketosis (HP:0001946) | 4.23299090 |
19 | Fat malabsorption (HP:0002630) | 4.19300386 |
20 | Abnormality of complement system (HP:0005339) | 4.17664336 |
21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.17190903 |
22 | Abnormality of methionine metabolism (HP:0010901) | 4.16955408 |
23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.06359786 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.01329667 |
25 | Abnormality of glycine metabolism (HP:0010895) | 3.88216549 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88216549 |
27 | Hypoglycemic coma (HP:0001325) | 3.87291223 |
28 | Hyperglycinuria (HP:0003108) | 3.85949934 |
29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.76304105 |
30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.76216126 |
31 | Hypercholesterolemia (HP:0003124) | 3.61934073 |
32 | Hyperbilirubinemia (HP:0002904) | 3.35168278 |
33 | Spontaneous abortion (HP:0005268) | 3.31462823 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30633525 |
35 | * Abnormality of the intrinsic pathway (HP:0010989) | 3.27379830 |
36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26326765 |
37 | Steatorrhea (HP:0002570) | 3.16764570 |
38 | Hypochromic microcytic anemia (HP:0004840) | 3.11719333 |
39 | Delayed CNS myelination (HP:0002188) | 3.07276445 |
40 | Myocardial infarction (HP:0001658) | 3.04222684 |
41 | Abnormality of serum amino acid levels (HP:0003112) | 3.02436371 |
42 | Hepatocellular carcinoma (HP:0001402) | 3.00654924 |
43 | Abnormality of nucleobase metabolism (HP:0010932) | 2.99891800 |
44 | Ketoacidosis (HP:0001993) | 2.97302106 |
45 | Purpura (HP:0000979) | 2.91730111 |
46 | Systemic lupus erythematosus (HP:0002725) | 2.89351237 |
47 | Skin nodule (HP:0200036) | 2.76277176 |
48 | Metabolic acidosis (HP:0001942) | 2.70798992 |
49 | Osteomalacia (HP:0002749) | 2.69264175 |
50 | Acanthocytosis (HP:0001927) | 2.62898928 |
51 | Abnormality of purine metabolism (HP:0004352) | 2.61729637 |
52 | Vascular calcification (HP:0004934) | 2.58812545 |
53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56195542 |
54 | Lethargy (HP:0001254) | 2.54651977 |
55 | Hypoglycemic seizures (HP:0002173) | 2.52617618 |
56 | Glomerulonephritis (HP:0000099) | 2.52034809 |
57 | Abnormal gallbladder morphology (HP:0012437) | 2.51520536 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50919075 |
59 | Dicarboxylic aciduria (HP:0003215) | 2.50919075 |
60 | Mitral stenosis (HP:0001718) | 2.47548111 |
61 | Cholelithiasis (HP:0001081) | 2.45885990 |
62 | Arthropathy (HP:0003040) | 2.43042962 |
63 | Amyloidosis (HP:0011034) | 2.42874407 |
64 | Spastic diplegia (HP:0001264) | 2.42097972 |
65 | Gout (HP:0001997) | 2.39499276 |
66 | Gingival bleeding (HP:0000225) | 2.38060613 |
67 | Cerebral edema (HP:0002181) | 2.37316178 |
68 | Neonatal onset (HP:0003623) | 2.36062975 |
69 | Abnormal gallbladder physiology (HP:0012438) | 2.34463100 |
70 | Cholecystitis (HP:0001082) | 2.34463100 |
71 | Irritability (HP:0000737) | 2.31875695 |
72 | Cardiovascular calcification (HP:0011915) | 2.29488978 |
73 | Pulmonary embolism (HP:0002204) | 2.28258521 |
74 | Malnutrition (HP:0004395) | 2.26522436 |
75 | Fair hair (HP:0002286) | 2.22497641 |
76 | Esophageal varix (HP:0002040) | 2.22099647 |
77 | Menorrhagia (HP:0000132) | 2.21510847 |
78 | Thrombophlebitis (HP:0004418) | 2.20234833 |
79 | Sensorimotor neuropathy (HP:0007141) | 2.16068274 |
80 | Pancreatitis (HP:0001733) | 2.13511619 |
81 | Poikilocytosis (HP:0004447) | 2.11558776 |
82 | Enlarged kidneys (HP:0000105) | 2.10575366 |
83 | Late onset (HP:0003584) | 2.09907529 |
84 | Hemorrhage of the eye (HP:0011885) | 2.08722806 |
85 | Brushfield spots (HP:0001088) | 2.07765429 |
86 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05190545 |
87 | Abnormality of the gallbladder (HP:0005264) | 2.03943865 |
88 | Vomiting (HP:0002013) | 2.03712612 |
89 | Opisthotonus (HP:0002179) | 2.02257640 |
90 | Generalized aminoaciduria (HP:0002909) | 1.97571408 |
91 | Hyperphosphaturia (HP:0003109) | 1.96443340 |
92 | Abnormality of iron homeostasis (HP:0011031) | 1.96155067 |
93 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93094907 |
94 | Rickets (HP:0002748) | 1.91422050 |
95 | Hypophosphatemic rickets (HP:0004912) | 1.88932804 |
96 | Abnormality of the Achilles tendon (HP:0005109) | 1.86938725 |
97 | Joint swelling (HP:0001386) | 1.85359948 |
98 | Epistaxis (HP:0000421) | 1.85079421 |
99 | Increased serum pyruvate (HP:0003542) | 1.83169825 |
100 | Abnormal cartilage morphology (HP:0002763) | 1.82844976 |
101 | Reduced antithrombin III activity (HP:0001976) | 1.82658512 |
102 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81855076 |
103 | Potter facies (HP:0002009) | 1.81798283 |
104 | Facial shape deformation (HP:0011334) | 1.81798283 |
105 | Elevated hepatic transaminases (HP:0002910) | 1.81422051 |
106 | Renal cortical cysts (HP:0000803) | 1.80896863 |
107 | Abnormality of proline metabolism (HP:0010907) | 1.80282587 |
108 | Hydroxyprolinuria (HP:0003080) | 1.80282587 |
109 | Glycosuria (HP:0003076) | 1.79913628 |
110 | Abnormality of urine glucose concentration (HP:0011016) | 1.79913628 |
111 | Nephritis (HP:0000123) | 1.78880912 |
112 | Status epilepticus (HP:0002133) | 1.78055405 |
113 | Abnormal tarsal ossification (HP:0008369) | 1.76541914 |
114 | Reticulocytosis (HP:0001923) | 1.74914535 |
115 | Hyperglycemia (HP:0003074) | 1.74189409 |
116 | Alkalosis (HP:0001948) | 1.73272777 |
117 | Bifid scrotum (HP:0000048) | 1.72697915 |
118 | Elevated alkaline phosphatase (HP:0003155) | 1.71718227 |
119 | Neonatal hypoglycemia (HP:0001998) | 1.67931139 |
120 | Abnormal urine phosphate concentration (HP:0012599) | 1.63860469 |
121 | Hypothermia (HP:0002045) | 1.62285920 |
122 | Gangrene (HP:0100758) | 1.61750010 |
123 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.60744606 |
124 | Increased serum ferritin (HP:0003281) | 1.60035781 |
125 | Abnormality of glycolysis (HP:0004366) | 1.59819967 |
126 | Abnormality of vitamin metabolism (HP:0100508) | 1.58395834 |
127 | Abnormality of carpal bone ossification (HP:0006257) | 1.58027443 |
128 | Increased mean platelet volume (HP:0011877) | 1.53407650 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.02848483 |
2 | FGFR4 | 4.77013732 |
3 | SIK1 | 4.55167221 |
4 | ERN1 | 4.53736799 |
5 | TAOK3 | 3.23934326 |
6 | ERBB4 | 3.17349320 |
7 | INSRR | 2.98511188 |
8 | WNK4 | 2.84639082 |
9 | MAP2K4 | 2.31725805 |
10 | CDK12 | 2.28613305 |
11 | MST1R | 2.10619524 |
12 | PKN2 | 2.08507715 |
13 | MAPK11 | 2.00754374 |
14 | PIK3CG | 1.89242213 |
15 | FLT3 | 1.83022864 |
16 | AKT3 | 1.79934074 |
17 | TYK2 | 1.77817640 |
18 | NTRK3 | 1.77226020 |
19 | TRIB3 | 1.75601511 |
20 | DAPK2 | 1.66915118 |
21 | LATS1 | 1.64527076 |
22 | PTK6 | 1.54660244 |
23 | FGFR1 | 1.48593238 |
24 | NLK | 1.46079799 |
25 | ABL2 | 1.43050878 |
26 | NEK9 | 1.41561794 |
27 | PDGFRA | 1.38268586 |
28 | FGFR2 | 1.36760088 |
29 | MAP3K2 | 1.33273689 |
30 | KDR | 1.33148023 |
31 | JAK2 | 1.29409524 |
32 | FRK | 1.26972448 |
33 | MAP3K7 | 1.20080412 |
34 | ERBB2 | 1.12263311 |
35 | TYRO3 | 1.12083709 |
36 | PRKAA2 | 1.08998644 |
37 | JAK1 | 1.05625368 |
38 | GRK6 | 1.04720911 |
39 | PINK1 | 1.04542299 |
40 | MAP2K3 | 1.04478811 |
41 | TBK1 | 1.04429912 |
42 | WNK1 | 1.04108537 |
43 | MAP3K10 | 1.03301625 |
44 | WNK3 | 1.02284217 |
45 | MAP3K14 | 0.97309156 |
46 | MAPK4 | 0.96605269 |
47 | EPHB1 | 0.91534265 |
48 | MAPK15 | 0.90277527 |
49 | PRKCZ | 0.89578596 |
50 | MET | 0.86529049 |
51 | EPHA3 | 0.85388107 |
52 | SGK1 | 0.83343364 |
53 | SIK2 | 0.80422731 |
54 | CDK6 | 0.80210091 |
55 | MAPK12 | 0.79535179 |
56 | STK38L | 0.79316156 |
57 | MAP3K3 | 0.78517115 |
58 | TIE1 | 0.77885651 |
59 | MAP3K11 | 0.76530624 |
60 | PRKACG | 0.76360594 |
61 | FER | 0.73746152 |
62 | CAMK2G | 0.73738989 |
63 | DDR2 | 0.72693759 |
64 | CSNK1E | 0.72309427 |
65 | DYRK1B | 0.70703096 |
66 | MAPKAPK3 | 0.69783442 |
67 | STK16 | 0.69079375 |
68 | CSK | 0.68585502 |
69 | PRKG1 | 0.67788781 |
70 | CDC42BPA | 0.66766320 |
71 | PRKAA1 | 0.65015530 |
72 | GSK3A | 0.64699227 |
73 | CAMK1D | 0.64456629 |
74 | EIF2AK1 | 0.64238106 |
75 | MAP2K6 | 0.63034867 |
76 | RPS6KB1 | 0.61154743 |
77 | SGK3 | 0.60270153 |
78 | BCR | 0.59811774 |
79 | RIPK1 | 0.59179229 |
80 | FGFR3 | 0.59152542 |
81 | TGFBR2 | 0.57360250 |
82 | PTK2 | 0.56965720 |
83 | CSNK1D | 0.56652428 |
84 | MAPK7 | 0.55973913 |
85 | IRAK3 | 0.55654462 |
86 | CSF1R | 0.54992436 |
87 | PRKACA | 0.54383598 |
88 | IKBKE | 0.53662203 |
89 | PKN1 | 0.53166841 |
90 | EPHA4 | 0.50481312 |
91 | PDPK1 | 0.49980978 |
92 | PRKCQ | 0.49444615 |
93 | TAOK2 | 0.46371838 |
94 | RPS6KA3 | 0.45960983 |
95 | GRK1 | 0.44996684 |
96 | SRC | 0.43853234 |
97 | SGK2 | 0.43522171 |
98 | CSNK1G1 | 0.43293680 |
99 | IGF1R | 0.43053408 |
100 | MAP3K13 | 0.42539457 |
101 | MAP3K5 | 0.42255936 |
102 | RET | 0.41747390 |
103 | MAP2K1 | 0.40697025 |
104 | CDK4 | 0.40564496 |
105 | PRKCG | 0.40312349 |
106 | ICK | 0.39952631 |
107 | EEF2K | 0.38504661 |
108 | CSNK2A2 | 0.36474819 |
109 | FGR | 0.36377886 |
110 | EGFR | 0.36211037 |
111 | PRKCB | 0.36070678 |
112 | MTOR | 0.35913373 |
113 | STK39 | 0.35445504 |
114 | CDK7 | 0.35352705 |
115 | CAMKK2 | 0.35071158 |
116 | PBK | 0.33955856 |
117 | MAP3K6 | 0.33326701 |
118 | CSNK2A1 | 0.33141646 |
119 | BRSK2 | 0.33109723 |
120 | MAP3K1 | 0.32515904 |
121 | CAMK4 | 0.32228930 |
122 | SGK494 | 0.30756537 |
123 | SGK223 | 0.30756537 |
124 | PDK1 | 0.30115157 |
125 | LATS2 | 0.26606167 |
126 | KSR2 | 0.26143294 |
127 | PRKCA | 0.25762457 |
128 | PIK3CA | 0.22896618 |
129 | CSNK1G2 | 0.22882081 |
130 | PAK3 | 0.22652466 |
131 | IRAK1 | 0.22453728 |
132 | TNK2 | 0.21589378 |
133 | ABL1 | 0.21547236 |
134 | CAMK1G | 0.20630202 |
135 | BMX | 0.20561450 |
136 | MAPK1 | 0.20450506 |
137 | CSNK1G3 | 0.19861038 |
138 | PDK2 | 0.19843865 |
139 | PRKACB | 0.18688384 |
140 | MAPK3 | 0.18628309 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.63091105 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.62728805 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37943904 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28380726 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06819941 |
6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.86534565 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70277032 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66133833 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64973240 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55938374 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46507412 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36292955 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18941993 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14612259 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10551510 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.06942898 |
17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93857872 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92862047 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90697829 |
20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89431727 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89128567 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85805859 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85364046 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78884067 |
25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77714074 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75823876 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73237551 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69003180 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67459199 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62727032 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61166521 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59101331 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55436511 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49720856 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49587069 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.49077773 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45990358 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33748645 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33058723 |
40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31569841 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30159524 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26519724 |
43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22102685 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.21975056 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20646722 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19680888 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18529552 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11154655 |
49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04513434 |
50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03461922 |
51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00677581 |
52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98429022 |
53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97387360 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96053331 |
55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94936293 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87061794 |
57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86864609 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82055391 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79995314 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78587729 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68649764 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65789192 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62635070 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56228667 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52237587 |
66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45387782 |
67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44631141 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43542367 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.43235960 |
70 | Pertussis_Homo sapiens_hsa05133 | 0.41844110 |
71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35905446 |
72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26847758 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26533629 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.23416611 |
75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22819525 |
76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22306471 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21723722 |
78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19688669 |
79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15893784 |
80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10493422 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.10446854 |
82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01401571 |
83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00558879 |
84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2413937 |
85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2392265 |
86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2298598 |
87 | Amoebiasis_Homo sapiens_hsa05146 | -0.2181324 |
88 | Bladder cancer_Homo sapiens_hsa05219 | -0.2158188 |
89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2062566 |
90 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2015437 |
91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1937403 |
92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1924188 |
93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1880740 |
94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1793727 |
95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1727080 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1695558 |
97 | Hepatitis C_Homo sapiens_hsa05160 | -0.1645173 |
98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1559669 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1449566 |
100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1414168 |
101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1209209 |
102 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1204850 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1031374 |
104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0872078 |
105 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0866591 |
106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0719488 |
107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0707709 |
108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0678013 |
109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0544461 |
110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0520091 |